Articles

DOT1L inhibition blocks multiple myeloma cell proliferation by suppressing IRF4-MYC signaling

Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine;Department of Molecular Biology, Sapporo Medical University School of Medicine
Department of Molecular Biology, Sapporo Medical University School of Medicine
Department of Molecular Biology, Sapporo Medical University School of Medicine
Department of Hematology, Japanese Red Cross Medical Center, Tokyo
Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo
Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine
Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine
Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine
Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine
Department of Molecular Biology, Sapporo Medical University School of Medicine
Department of Molecular Biology, Sapporo Medical University School of Medicine
Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine;Department of Molecular Biology, Sapporo Medical University School of Medicine
Department of Molecular Biology, Sapporo Medical University School of Medicine
Department of Medical Genome Sciences, Research Institute for Frontier Medicine and Sapporo Medical University School of Medicine, Japan
Department of Medical Genome Sciences, Research Institute for Frontier Medicine and Sapporo Medical University School of Medicine, Japan
Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine
Department of Molecular Biology, Sapporo Medical University School of Medicine
Vol. 104 No. 1 (2019): January, 2019 https://doi.org/10.3324/haematol.2018.191262